Dr. Yasser Bahader

Professor & Consultant of Radiation Oncology

Faculty of Medicine, King Abdulaziz University

10 : 25 – 10 : 40

24 June | 2023 Day 2

Prostate irradiation in men with de novo, low-volume, metastatic, castration-sensitive prostate cancer (mCSPC): Results of PEACE-1, a phase 3 randomized trial with a 2x2 design

4th PSMMC ASCO Data Review Meeting (PADRM). This meeting will highlight the top most clinically relevant achievements of ASCO 2023 for different and commonest tumor types.